Schemel Donald Robert 4
4 · Sun BioPharma, Inc. · Filed Jun 26, 2020
Insider Transaction Report
Form 4
Schemel Donald Robert
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-24+13,700→ 13,700 totalExercise: $4.98Exp: 2030-06-24→ Common Stock (13,700 underlying)
Footnotes (1)
- [F1]Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2021.